A23G (p.Ala23Gly) variant of ATRX (Chromatin remodeler ATRX)
A23G (p.Ala23Gly) in ATRX (Chromatin remodeler ATRX) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.24 / 1. The record also includes structural context.
A23G (p.Ala23Gly) variant details
- p.Ala23Gly
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.241
- ESM-1b 0.00
- AlphaMissense 0.37
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available